Drug Type Small molecule drug |
Synonyms SBS-371, TJ-171, TJ-3-345 + [2] |
Target |
Mechanism μ opioid receptor antagonists(Mu opioid receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization Sparian Biosciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Opiate Overdose | Preclinical | US | Sparian Biosciences, Inc.Startup | 29 Aug 2022 |